c Botulinum neurotoxins (BoNTs) possess unique specificity for nerve terminals. They bind to the presynaptic membrane and then translocate intracellularly, where the light-chain endopeptidase cleaves the SNARE complex proteins, subverting the synaptic exocytosis responsible for acetylcholine release to the synaptic cleft. This inhibits acetylcholine binding to its receptor, causing paralysis. Binding, an obligate event for cell intoxication, is believed to occur through the heavy-chain C-terminal (H C ) domain. It is followed by toxin translocation and entry into the cell cytoplasm, which is thought to be mediated by the heavy-
Botulinum neurotoxins (BoNTs) are the most potent toxins and are ranked by the Centers for Disease Control and Prevention (CDC) as bioterrorism threats with the six highest-risk class A agents (1). The potency of the toxin is due to its outstanding specificity to nerve terminals and selective enzymatic activity, resulting in the cleavage of SNARE (soluble N-ethylmaleimidesensitive factor attachment protein receptor) complex proteins. The cleavage of SNARE proteins inhibits the fusion of synaptic vesicles (containing the neurotransmitter) to the plasma membrane, thereby blocking neurotransmitter release and causing paralysis (2, 3).Unraveling the features of the mode of action of BoNTs has permitted numerous applications of the toxins in many therapeutic, pharmaceutical, and cosmetic applications (4-7). However, understanding of the full biochemical mechanism of its action still remains to be elucidated.BoNTs, produced by Gram-positive, obligate anaerobic Clostridium botulinum bacteria, are classified into eight different serotypes (A through H) (8-10). BoNTs are expressed as a single polypeptide chain (ϳ150 kDa) which is posttranslationally cleaved to produce an N-terminal light (L) chain of ϳ50 kDa, which is a Zn 2ϩ metalloprotease, and a heavy (H) chain of ϳ100 kDa. The L and H chains are linked together by a disulfide bond and other noncovalent interactions to form the active toxin. The H chain is further functionally divided into two seemingly independent domains: the N-terminal or translocation (H N ) domain and the Cterminal receptor-binding (H C ) domain (11).The entry of BoNT into neurons and its resultant toxicity are exhibited in a systematic manner, accomplished by a superb molecular partnership between the H and L chains. It is believed that an intricate mechanism involving various low-and high-affinity interactions is involved in intoxication of the cell (12). The difference in pH and redox potential across the endosomes is believed to induce conformational changes in the H chain, which subsequently forms a chaperone and channels the L chain into the cytosol. Once the L chain is translocated, it is subsequently released by disulfide bond reduction, followed by its refolding in the neutral cytosol, where it cleaves the SNARE substrates (13). The current understanding of toxin entry into the cell is that the H C domain binds to the neurons via dual host receptors (gangliosides...